The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. This study is a randomized controlled trial to evaluate the effect of this mobile-based intervention. The investigators' hypothesis is that subjects randomized to the intervention group will have a reduction in pain and pain-related hospitalizations.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
110
A mobile application designed to help cancer patients better self-manage cancer pain.
The Massachusetts General Hospital
Boston, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
Pain symptoms using the Brief Pain Inventory
The primary aim is to assess the effect of a tailored, multi-dimensional mobile-based intervention on the intensity of cancer pain in cancer patients with moderate to severe pain.
Time frame: up to 8 weeks
Pain related hospitalization from the Electronic Health Record
* In-patient and out-patient hospital visits * Urgent non-scheduled clinic visits for pain crisis
Time frame: up to 8 weeks
Patient-related barriers to pain management using the Barriers Questionnaire-II
compared patient-related barriers to pain management using the Barriers Questionnaire-II (BQ-II)
Time frame: up to 8 weeks
Engagement as tracked by the app
Pattern of patient engagement with the study's mobile application
Time frame: up to 8 weeks
Anxiety symptoms using the Generalized Anxiety Disorder (GAD-7)
compare anxiety symptoms between the two group using the Generalized Anxiety Disorder (GAD-7)
Time frame: up to 8 weeks
Quality of life using the Functional Assessment of Cancer Therapy (FACT-G)
to compare quality of life between the two groups using the Functional Assessment of Cancer Therapy -General (FACT-G)
Time frame: up to 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.